102 related articles for article (PubMed ID: 9261743)
1. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon.
Tsukada N; Aoki S; Maruyama S; Kishi K; Takahashi M; Aizawa Y
J Exp Clin Cancer Res; 1997 Jun; 16(2):171-6. PubMed ID: 9261743
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
[TBL] [Abstract][Full Text] [Related]
4. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
5. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
Subauste CS; de Waal Malefyt R; Fuh F
J Immunol; 1998 Feb; 160(4):1831-40. PubMed ID: 9469444
[TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells.
Li H; Liu ZH; Dai CS; Liu D; Li LS
Acta Pharmacol Sin; 2002 Sep; 23(9):775-81. PubMed ID: 12230943
[TBL] [Abstract][Full Text] [Related]
7. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1.
Love KS; Lakshmanan RR; Butterfield JH; Fox CC
Cell Immunol; 1996 May; 170(1):85-90. PubMed ID: 8660803
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
10. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE
J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593
[TBL] [Abstract][Full Text] [Related]
11. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
12. Expression of major histocompatibility complex class II and costimulatory molecules in oral carcinomas in vitro.
Villarroel-Dorrego M; Speight PM; Barrett AW
Med Oral Patol Oral Cir Bucal; 2005; 10(3):188-95. PubMed ID: 15876961
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells.
Yokozeki H; Katayama I; Ohki O; Arimura M; Takayama K; Matsunaga T; Satoh T; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):831-7. PubMed ID: 9217813
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
15. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
16. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma.
Tatsumi T; Takehara T; Katayama K; Mochizuki K; Yamamoto M; Kanto T; Sasaki Y; Kasahara A; Hayashi N
Hepatology; 1997 May; 25(5):1108-14. PubMed ID: 9141426
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes.
Guerder S; Eynon EE; Flavell RA
J Immunol; 1998 Sep; 161(5):2128-40. PubMed ID: 9725204
[TBL] [Abstract][Full Text] [Related]
18. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
[TBL] [Abstract][Full Text] [Related]
19. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
[TBL] [Abstract][Full Text] [Related]
20. CD40 and IFN-gamma dependent T cell activation by human bronchial epithelial cells.
Tanaka H; Maeda K; Nakamura Y; Azuma M; Yanagawa H; Sone S
J Med Invest; 2001 Feb; 48(1-2):109-17. PubMed ID: 11286011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
